CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The REGENERAR project aims to develop a non-viral delivery system for reprogramming glial cells into neurons, addressing the need for neuron replacement after injuries. It will assess safety and effectiveness through various testing methods.
The central nervous system has a limited capacity for self-repair.
Therefore, technologies to replace lost neurons after an injury, including stroke or neurodegenerative diseases, are of great need.
The project REGENERAR aims to develop a non-viral delivery formulation up to TRL4 for the delivery of an epigenetic reprogramming formulation to reprogram glial cells into neurons.
The in vitro safety and targeting of the formulation will be tested against glial cells and organotypic cortical slice…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Portugal, Porto
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Sweden, Stockholm
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
